Skip to main content

Together we are beating cancer

Donate now

Dances with Pharma

Showing 2 out of 2 results

In the second part of this two-part series, we look at our work with industry, why it's important, and how we try to influence the way drugs get to patients. In the second part of this two-part series, we look at our work with industry, why it's important, and how we try to influence the way drugs get to patients.

by Emma Smith | Analysis | 17 December 2014

17 December 2014

This entry is part 2 of 2 in the series Dances with Pharma
Drugs

In this first in a two-part series, we take a look at how cancer drugs get to patients, and at some of reasons behind the spiralling costs. In this first in a two-part series, we take a look at how cancer drugs get to patients, and at some of reasons behind the spiralling costs.

by Emma Smith | Analysis | 16 December 2014

16 December 2014

This entry is part 1 of 2 in the series Dances with Pharma